Standard Peripheral IV Cannula (14G–26G)
- ISO 10555-5 compliant FEP/PU tubing
- Tri-facet siliconized bevel needle
- Color-coded hubs for rapid size ID
MEDICA 2026 | 16–19 November 2026 | Hall 6, Stall F37 | Düsseldorf, Germany
Engineered for high-turnover clinical environments, trauma centers, veterinary care, and outpatient facilities in Greater Boston. Manufactured under strict ISO 13485:2016 and CE standards.
An in-depth analysis of supply chain resilience, regulatory alignment, and technological innovation required for New England's premier life sciences ecosystem.
The Greater Boston metropolitan area—anchored by the Longwood Medical Area, Cambridge’s Kendall Square bio-cluster, and the Route 128 medtech corridor—stands as the world’s foremost nexus of clinical healthcare, medical device innovation, and academic medicine. With world-renowned hospital networks such as Mass General Brigham, Beth Israel Deaconess Medical Center (BIDMC), Boston Children’s Hospital, and Tufts Medical Center, the regional demand for high-spec, ultra-reliable single-use medical devices is unmatched in density and technical rigor.
However, OEMs, medtech startups, and clinical supply distributors headquartered in Boston face intense pressure: escalating raw material costs, regulatory audits under FDA 21 CFR 820, strict OSHA bloodborne pathogen standards, and the mandate for supply chain anti-fragility. Sourcing medical disposables from an experienced offshore/nearshore original equipment manufacturer (OEM) that bridges high-volume precision assembly with ISO 13485:2016 quality systems has evolved from a cost-reduction tactic into a strategic imperative.
Boston healthcare procurement teams are transitioning away from fragmented vendor chains toward vertically integrated OEM factories capable of controlling tooling, molding, needle assembly, and sterilization under one roof. This minimizes batch variance, ensures 100% traceabilities, and drastically shortens regulatory registration cycles for FDA 510(k) clearances and European MDR requirements.
For Boston-based medical device brand owners and procurement directors, regulatory friction is the single greatest bottleneck to market entry. Our manufacturing architecture is calibrated specifically to eliminate compliance friction:
Tailored OEM configurations designed to meet specific clinical demands across regional trauma, pediatric, ambulatory, and veterinary environments.
In high-velocity emergency hubs like Mass General and Boston Medical Center, rapid flashback identification and high-flow vascular access are critical. Our 14G–18G safety IV cannulas feature ultra-thin wall FEP tubing and blood control technology (BCT) to reduce blood splatter during chaotic resuscitations.
Pediatric care at facilities like Dana-Farber Cancer Institute requires delicate venipuncture. Our 24G and 26G micro-gauge safety catheters incorporate lubricated tri-facet needles and DEHP-free micro-drip infusion sets to protect fragile vessels and prevent chemical leaching.
Boston’s rapidly expanding outpatient surgery centers demand cost-effective, ergonomic, single-use disposables. Our pre-assembled closed loop IV catheter systems reduce setup time, minimize contamination risks, and streamline clinical throughput.
Across Cambridge biotechnology labs and New England veterinary hospitals, precise fluid delivery is essential. We manufacture specialty butterfly IV catheters and small-gauge animal infusion sets engineered for canine, feline, and laboratory animal protocols.
Multi-line IV administration in Intensive Care Units demands pressure-tested components. Our 3-way stopcocks, moulded from high-clarity lipid-resistant polycarbonate, withstand pressure up to 4.5 bar and prevent drug interaction.
We partner with Boston-based medical distributors competing for municipal and state healthcare contracts, offering turnkey private labeling, customized pouch artwork, UDI compliance, and full technical dossier support.
Comprehensive engineering parameters for Boston medtech engineers and procurement evaluators.
| Parameter / Component | FEP Catheter Option | Polyurethane (PUR) Option | 3-Way Stopcock Hub | DEHP-Free Infusion Line |
|---|---|---|---|---|
| Primary Material | Fluorinated Ethylene Propylene | Thermoplastic Polyurethane | Lipid-Resistant Polycarbonate | Phthalate-Free Medical PVC |
| Biocompatibility | ISO 10993 Passed | ISO 10993 Passed | ISO 10993 Passed | ISO 10993 Passed |
| Needle Sharpening | 3-Facet Siliconized Bevel | 3-Facet Siliconized Bevel | N/A (Luer Lock Hub) | N/A (ABS Spike Piercer) |
| Kink Resistance | High Memory Recovery | Superior Softening in Vein | Rigid High-Pressure Body | Non-Torsion Flexible Tubing |
| Sterilization Method | Ethylene Oxide (EO) | Ethylene Oxide (EO) | Ethylene Oxide (EO) | Ethylene Oxide (EO) / Gamma |
| Luer Taper Standard | ISO 80369-7 Compliant | ISO 80369-7 Compliant | ISO 80369-7 360° Rotate | ISO 80369-7 Male/Female |
Key technological shifts driving purchasing specifications across New England medical centers.
Under OSHA bloodborne pathogen guidelines and stringent hospital risk management policies across Massachusetts, legacy non-safety catheters are rapidly being phased out. Modern procurement favors passive safety mechanisms—such as integrated spring clips that auto-encapsulate the needle tip upon withdrawal—over manual active shields, reducing user error and clinical needle-stick injuries to zero.
Boston healthcare systems lead the nation in environmental health standards. Hospitals are demanding DEHP-free and phthalate-free infusion sets to avoid toxic leaching during neonatal care, chemotherapy administration, and prolonged ICU infusion. Our proprietary formulation uses alternative plasticizers (such as TOTM or DINCH) ensuring total clinical peace of mind.
Vascular access procedures frequently cause blood leakage during catheter insertion prior to extension set attachment, creating biohazard risks and requiring extra cleanup time. OEM catheters with integrated septums automatically restrict blood flow from the hub until a luer connection is established, keeping clinicians safe and maintaining sterile surgical drapes.
To combat ocean freight disruptions and port bottlenecks, Boston medical distributors require manufacturers with regional support hubs. With our North American operations office in Milton, Ontario, Lars Medicare offers real-time order coordination, inventory buffering, and expedited air/sea container routing via Boston Logan International Airport and the Port of Boston.
Vertical integration, decades of export expertise, and unwavering devotion to clinical precision.
Our state-of-the-art facility features a dedicated tool room and high-precision injection moulding shop. We design custom moulds, alter hub configurations, and adjust gauge mixes without relying on third-party sub-contractors.
Every shipment comes complete with CE Certificates, ISO 13485:2016 accreditation, EC Declarations of Conformity, Free Sale Certificates, batch-wise CoA, and EO validation reports formatted for seamless FDA submission.
From custom blister packaging artwork and multilingual IFU inserts to UDI-ready barcoding and inner box design, we deliver market-ready finished medical devices under your brand identity.
Essential answers regarding regulatory documentation, custom branding, logistics, and quality assurance for Greater Boston buyers.